PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Value in Health0 citations

What is the Consensus Value of Patients’ Treatment-Risk Tolerance? Assessing a Stated-Preference Evidence Base for Inflammatory Bowel Disease

View Full Paper
FJFreed JohnsonASAmit K. SrivastavaJYJui-Chen Yang

Key Points

  • Patients express varying levels of treatment-risk tolerance for inflammatory bowel disease, emphasizing distinct preferences.
  • The study highlights that understanding these preferences is crucial for tailored treatment strategies, enhancing patient satisfaction.
  • Observational analysis collecting stated-preference data from patients was conducted, emphasizing the importance of personalized care.
  • Findings may enable healthcare providers to offer better treatment options aligned with patient values, improving outcomes.
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Johnson et al. (2026) studied this question.

synapsesocial.com/papers/69a7603fc6e9836116a2ccb1https://doi.org/10.1016/j.jval.2026.01.012
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Quantifying Patient Preferences for Risk Tolerance With Novel Dual Biologic Therapies for Inflammatory Bowel Disease2025 · 2 citations
  2. 2On Approximating the Statistical Properties of Elasticities1986 · 2,393 citations
  3. 3PR2 QUANTIFYING PATIENTS' RISK-BENEFIT TRADEOFF PREFERENCES: A CONCEPTUAL AND EMPIRICAL COMPARISON OF METHODS2006 · 1 citations
  4. 4The Risk-Benefit Balance In The United States: Who Decides?2007 · 5 citations
  5. 5A Joint Estimation Method to Combine Dichotomous Choice CVM Models with Count Data TCM Models Corrected for Truncation and Endogenous Stratification2008 · 28 citations